Olympus sets aside $450M for expected settlement, EndoChoice launches IPO of 6.25M shares & more – 6 GI/endoscopy company key notes

Here are six news updates on key gastroenterology and endoscopy companies.

EndoChoice launched its initial public offering. The IPO represents 6.25 million shares of common stock, 25.6 percent of the company's outstanding common stock following its conversion into a Delaware corporation in connection with the offering.

Medigus has been listed and has begun trading American depository receipts on the NASDAQ Capital Market under the ticker symbol MDGS.

Olympus set aside $450 million for an expected settlement focused on its marketing of scopes tied to infections, according to an LA Times report.

Hoya Group PENTAX Medical launched its Splash M-Knife, designed for endoscopic submucosal dissection.

SonarMD, LLC, released its SonarMD platform, a population health management tool for inflammatory bowel disease.

Synthetic Biologics, a company focused on microbiome research, presented two posters at Digestive Disease Week this year.

If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.

More articles on gastroenterology:
URMC GI experts organize advanced endoscopy nursing course: 4 key notes
31 GI physicians making headlines – May 26, 2015
Dr. Michael Camilleri named AGA president: 5 things to know

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months